Trodusquemine, a spermine metabolite of cholesterol, is a naturally occurring aminosterol that inhibits protein tyrosine phosphatase 1B. It has demonstrated the ability to stimulate regeneration of heart and multiple other...
- Mechanism
- Curator reviewed
Trodusquemine is a spermine metabolite of cholesterol which possibly acts on the paraventricular nucleus in the hypothalamus. Trodusquemine suppresses feeding, prevents reduction in energy expenditure, causes hormonal changes, and induces patterns of neuropeptide expression normally associated with weight loss. Trosdusquemine enhances insulin sensitivity through inhibition of protein tyrosine phostphatase 1B centrally and peripherally (PTP-1B), dopamine and norepinephrine reuptake, an ion transport modulator and a downregulator of Agouti-related peptide (AgRP) and neuropeptide Y (NPY) expression.
- Primary indication
- Investigated for use/treatment in obesity and diabetes mellitus type 2.Curator reviewed
- Formula / weight
- C37H72N4O5S · 685.07 g/mol (avg)
- Code names
- MSI-1436
Resolves to
WUJVPODXELZABP-FWJXURDUSA-NSMILES[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCNCCCCNCCCN)[C@H](C)CC[C@@H](OS(O)(=O)=O)C(C)CWhat you can answer from here — as of August 29, 2026
Which drugs share a target with Trodusquemine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account